Pre-commercial life sciences companies turn to Sidley in the U.S., Europe, and Asia to help them navigate the complex legal issues that arise as they conduct their research and development activities and prepare to bring their products to market. Our transactional work spans formation and early-stage capital-raising through IPO and beyond, licensing and collaboration deals, operational agreements, and buy- and sell-side M&A transactions. Our healthcare and FDA regulatory teams counsel clients on issues related to conducting clinical trials, engaging with regulatory agencies for approval or marketing clearance, developing pricing, reimbursement, and market access/payer contracting strategies, and establishing quality systems and right-sized compliance programs. Our life sciences transactional, litigation and regulatory lawyers coordinate to leverage and protect a company’s intellectual property through an integrated patent and regulatory strategy and to reduce future enforcement risk.
On the Pulse of Global Life Sciences